EG 427 is a French biotechnology company that specializes in a novel approach to gene therapy known as pinpoint gene therapy. The company focuses on developing HSV-1-based vectors, leveraging the natural characteristics of Herpes Simplex Virus 1 to create targeted and long-lasting expression of therapeutic genes. This innovative method aims to address spinal cord injury-related disorders, particularly neurogenic bladder conditions, by providing physicians with a potential cure for patients suffering from severe, chronic, and localized diseases. Through its advanced research, EG 427 seeks to transform treatment options for individuals affected by these challenging medical issues.
Ayming
Acquisition in 2025
Ayming is a management consulting firm headquartered in Levallois, France, that focuses on optimizing operational performance for its clients. The company provides a range of services, including consulting on human resources costs, tax strategies, operational costs optimization, software solutions, and energy and environmental issues. Additionally, Ayming offers advisory services related to work contributions and wage audits. By leveraging these diverse consulting offerings, Ayming aims to help organizations enhance their efficiency and overall performance while effectively managing social costs associated with taxes and financial operations.
ENYO Pharma
Series C in 2024
ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, founded in 2014 by scientists from the Infectiology Research Center. The company focuses on drug discovery and development for the treatment of acute and chronic viral infections, utilizing a unique platform to identify intracellular therapeutic targets and molecules. ENYO Pharma is developing a pipeline of drug candidates addressing various indications, including hepatitis B virus, nonalcoholic steatohepatitis, and oncology. Its lead compound, EYP001, is designed to modulate specific nuclear receptors, aiming to reduce viral reservoirs and inhibit harmful viral protein expression. The company is also advancing EYP002 through preclinical studies. ENYO Pharma collaborates closely with established research institutions and aims to conduct its molecules into Phase II clinical trials, striving to become a global leader in antiviral therapeutics.
Andera Partners
Series A in 2023
Andera Partners, established in 2001, is a Paris-based private equity firm with a 250-year heritage tracing back to the Rothschild family. The firm manages over €2 billion, focusing on investments in unlisted companies across France and internationally. Andera Partners specializes in life sciences, growth capital, and sponsorless mezzanine debt, aiming to create long-term value for its investors.
HR Path
Private Equity Round in 2022
HR Path is a global consultancy focused on human capital management, with a team of over 500 consultants operating across North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting, offering a range of services to support businesses in their digital transformation. HR Path is an authorized reseller of various HR software solutions, including those from SAP, SuccessFactors, and Oracle HCM, among others. In addition to reselling, the company has developed its own HR software solutions, such as BiHRdy, a business intelligence tool; Pandore, a packaged HR, payroll, and time management solution; and Geef, a talent management system. The client portfolio includes a mix of large corporations, including CAC 40-listed companies, as well as small and medium-sized enterprises and public sector organizations, reflecting its versatility in meeting diverse client needs.
Lhyfe
Venture Round in 2022
Lhyfe is a French company founded in 2017 and based in Nantes, specializing in the design, development, and operation of industrial sites for the production of green hydrogen derived from renewable energy sources such as wind and solar power. The company focuses on creating sustainable and flexible production facilities that provide substantial quantities of clean hydrogen, aimed at facilitating the transition of various industrial sectors and transportation to a clean energy framework. Lhyfe targets two primary markets: heavy mobility, which includes trucks, buses, trains, and potentially maritime and air transport in the future, and industrial sectors such as chemistry, steel, and glass production, which are significant contributors to greenhouse gas emissions. By ensuring minimal environmental impact, Lhyfe is committed to delivering affordable green hydrogen to support a sustainable energy transition.
Atlantic Therapeutics Limited
Venture Round in 2021
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
Sogetrel
Acquisition in 2021
Sogetrel, S.A.S. is a prominent company specializing in the design, deployment, and maintenance of network infrastructures and digital communication solutions. Established in 1985 and headquartered in Issy les Moulineaux, France, Sogetrel operates branches in Belgium and Switzerland. The company provides a range of services, including the integration of telecommunications networks, IP security systems for video surveillance and access control, and support for smart city projects. Sogetrel serves a diverse clientele across various sectors such as telecommunications, public authorities, defense, transport, and utilities. By focusing on the development of very high-speed networks and offering both customized and turnkey solutions, Sogetrel aims to enhance the quality of life for citizens while promoting efficiency and sustainability in the regions it serves.
Sirsa
Venture Round in 2021
Sirsa, established in 2014 and based in Paris, France, is a consulting firm focused on sustainable transformation. The company specializes in evaluating existing processes and analyzing risks to define strategies for transforming operations. Sirsa offers a comprehensive suite of services that includes implementing strategic plans, managing action plans, reporting results, and providing compliance services. The firm caters to a diverse range of industries, including aerospace, defense, food products, electrical equipment, healthcare, energy, medical supplies, environmental, and software sectors. In addition, Sirsa has developed a software-as-a-service (SAAS) platform that measures companies' extra-financial footprint and impacts, further enhancing its commitment to sustainability and operational effectiveness.
MasterGrid
Private Equity Round in 2019
MasterGrid is a manufacturer and supplier of high-voltage electrical equipment based in Grenoble, France. Incorporated in 2019, the company, formerly known as Merlin Gerin, specializes in producing a range of products for the commercial and industrial sectors, including high, medium, and low-voltage equipment. MasterGrid focuses on the distribution, protection, control, and management of electrical systems, providing solutions that ensure safe and durable performance. In addition to its manufacturing capabilities, the company offers equipment handling services to meet the specific needs of its clients.
Olaqin
Acquisition in 2019
Olaqin is a healthcare service provider based in Suresnes, France, specializing in e-health solutions for healthcare professionals. The company distinguishes itself by offering tailored services to various sectors within the healthcare industry. Olaqin operates through a value-added distribution network, supplying SESAM-Vitale readers and associated software indirectly, while also engaging directly with hospitals and pharmacies via public and service contracts. Its offerings include centralized payment systems, securing electronic care sheets, updating Vitale cards, and ensuring secure access to online medical records. These services enhance operational efficiency for healthcare professionals by providing essential technological and management support.
Ellisphere
Acquisition in 2019
Ellisphere is a business intelligence company that provides decision-making information to executives and decision-makers in France and internationally through its BIGnet network. The company offers a comprehensive platform that delivers economic and financial information about trading partners, as well as insights into customer and supplier portfolios. Additionally, it provides guidance on legislation and regulatory compliance, helping businesses to develop effective customer-base strategies. By focusing on information management and data marketing, Ellisphere supports organizations in promoting and sustaining their growth and development.
HR Path
Private Equity Round in 2019
HR Path is a global consultancy focused on human capital management, with a team of over 500 consultants operating across North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting, offering a range of services to support businesses in their digital transformation. HR Path is an authorized reseller of various HR software solutions, including those from SAP, SuccessFactors, and Oracle HCM, among others. In addition to reselling, the company has developed its own HR software solutions, such as BiHRdy, a business intelligence tool; Pandore, a packaged HR, payroll, and time management solution; and Geef, a talent management system. The client portfolio includes a mix of large corporations, including CAC 40-listed companies, as well as small and medium-sized enterprises and public sector organizations, reflecting its versatility in meeting diverse client needs.
Tournus Equipement
Private Equity Round in 2019
Tournus Equipement, S.A.S. is a manufacturer based in Tournus, France, specializing in stainless steel environments for professional kitchens and supermarket fish counters. Established in 1910, the company provides a wide range of products, including mobile and modular professional kitchens, regeneration ovens, warmers, sterilizing cabinets, dishwashing equipment, and various stainless steel furniture and shelving solutions. Its offerings also encompass self-service lines for meal distribution, custom equipment, and accessories such as wash-basins, gutters, floor drains, trolleys, and containers. Tournus Equipement serves diverse sectors, including canteens in companies and schools, restaurants, hotels, bakeries, supermarkets, and transport catering services. The company is committed to delivering durable and customizable solutions tailored to meet the specific needs of its clients.
Verbraeken Infra
Acquisition in 2019
Verbraeken Infra NV is a Belgian company specializing in the construction and renovation of underground and overhead infrastructure networks across Europe and North Africa. Founded in 1966 and based in Temse, Belgium, the company provides a wide range of services, including earth and roadworks, pipeline and sewer installation, and electrical works such as the installation of underground transmission cables and public lighting maintenance. Verbraeken Infra also engages in the installation of traditional copper and coaxial cables, as well as advanced techniques like horizontal directional drilling and pipe jacking. With approximately 1,000 employees and annual sales of €140 million, the company has expanded its operations in France, Germany, and the Benelux region, strengthening its market position in Belgium and enhancing its capacity to serve gas, water, electricity, and telecom companies.
Atlantic Therapeutics Limited
Series B in 2019
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
Atlantic Therapeutics Limited
Private Equity Round in 2018
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
The Bioclinic Group
Private Equity Round in 2018
Bioclinic operates a network of medical analysis laboratories in the Ile-de-France region, serving health professionals, hospitals, clinics, care centers, and retirement homes. Founded in 1995 and based in Paris, the company specializes in areas such as molecular biology, genetics, antibiotic resistance, and reproductive health. By focusing on these fields, Bioclinic aims to provide clients and their patients with enhanced medical diagnostic results.
Skill & You
Acquisition in 2018
Skill & You is the leading provider of vocational e-learning in France, focusing on delivering real results and recognized qualifications such as BAC PRO, BEP, BP, BTS, and CAP. The company operates an online education and distance learning platform that offers customized courses tailored to the specific needs of learners and industries. By leveraging innovative pedagogy and adaptable educational technology, Skill & You empowers individuals to acquire professional skills necessary for career advancement or personal development. With a strong track record of successful educational initiatives, Skill & You is committed to addressing the challenges of employment by equipping learners with the skills needed to transform their lives.
ENYO Pharma
Series B in 2018
ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, founded in 2014 by scientists from the Infectiology Research Center. The company focuses on drug discovery and development for the treatment of acute and chronic viral infections, utilizing a unique platform to identify intracellular therapeutic targets and molecules. ENYO Pharma is developing a pipeline of drug candidates addressing various indications, including hepatitis B virus, nonalcoholic steatohepatitis, and oncology. Its lead compound, EYP001, is designed to modulate specific nuclear receptors, aiming to reduce viral reservoirs and inhibit harmful viral protein expression. The company is also advancing EYP002 through preclinical studies. ENYO Pharma collaborates closely with established research institutions and aims to conduct its molecules into Phase II clinical trials, striving to become a global leader in antiviral therapeutics.
Biogroup-LCD
Debt Financing in 2018
BIOGROUP-LCD, a major French player in local medical biology, supports more than 20,000 patients every day and offers more than 2000 routine and specialized daily examinations, based on performance and technological innovation. Partner at every moment between the patient and the medical profession, your laboratory participates in the screening, diagnosis, monitoring and prognosis of the most common pathologies to the most demanding, throughout your course of care. BIOGROUP-LCD develops for this purpose all its human and technological resources. The team of qualified, qualified medical biologists follows continuous and regular training.
Globe Groupe
Private Equity Round in 2017
GLOBE Groupe sa is a Paris-based advertising agency that specializes in strategic marketing and communication services. The company focuses on shopper marketing to create impactful consumer experiences that drive sales. It offers a range of services including strategic planning, non-media planning, talent casting, recruitment, training, payroll, and logistics such as storage, dispatch, and cold-chain management. GLOBE Groupe also implements marketing activation campaigns and provides tools for performance measurement, utilizing key performance indicators to assess the effectiveness of its strategies. The firm caters to various sectors including consumer goods, media, retail, and recruitment, ensuring that its clients can adapt to the evolving landscape of consumer behavior and promotional messaging. Through its secure online platform, myGLOBE, clients can monitor operations in real-time, enhancing transparency and communication throughout the marketing process.
TimeOne
Acquisition in 2017
TimeOne, established in 2016, is a global marketing services group formed by merging Public-Idées and Place des Leads. Headquartered in France with operations across Europe, Asia, South Africa, and South America, the company specializes in providing comprehensive digital marketing solutions. TimeOne's core offerings include programmatic advertising, native content marketing, performance-based campaigns, digital marketplace management, publishing services, and mobile marketing strategies. The company is renowned for its innovative approach to prescriptive marketing, driven by a robust data management platform (DMP) and a strong focus on research and development.
Allodiagnostic
Acquisition in 2017
Allodiagnostic SAS is a company based in Paris, France, specializing in real estate diagnostics for private individuals during the rental or sale of properties. Established in 2001, it provides essential assessments, including termite inspections, electrical evaluations, and energy performance ratings. As the first expert network for mandatory real estate diagnostics in France, Allodiagnostic serves both individual clients and real estate professionals, offering tailored solutions to meet various diagnostic needs. The company has operated as a subsidiary of Edmond de Rothschild (France) since July 2017.
Intech
Private Equity Round in 2017
Intech is a leading manufacturer of orthopedic instruments and implants dedicated to enhancing patient outcomes. Operating with a workforce of around 1,000 employees globally, the company provides comprehensive manufacturing solutions to medical device original equipment manufacturers (OEMs). Intech specializes in a wide range of surgical tools, including implants, sterilization cases, and trays, catering to various medical fields such as spine, hip, knee, sports medicine, and trauma surgery. With facilities located in the United States, France, and Malaysia, Intech is positioned as a one-stop shop for medical device OEMs, delivering both off-the-shelf and custom-made instruments efficiently and cost-effectively.
Groupe 3S
Private Equity Round in 2017
Groupe 3S SAS, founded in 2001 and based in Roissy-en-France, France, specializes in providing a comprehensive range of ground handling and airport management services. The company offers essential services to airlines and airport operators, including passenger and baggage handling, load control, ramp activities, and crew management. Additionally, Groupe 3S delivers airport services such as assistance for persons with disabilities, management of taxi areas, cleaning of airports, aircraft de-icing, and runway maintenance. The organization also engages in industrial cleaning, ultra-cleanliness, facility management, and home support services for individuals. Moreover, it provides aviation security training, dangerous goods handling, and ground handling training courses. Through the synergy of expertise from its subsidiaries, Groupe 3S has established itself as a prominent player in the global services market.
Klaxcar
Acquisition in 2017
Klaxcar France S.A., founded in 1993 and headquartered in Dourdan, France, specializes in the design and manufacture of automotive spare parts for the aftermarket sector. The company provides Original Part quality products at competitive prices, offering a diverse range of components including lamps, wiper blades, glow and spark plugs, horns, belts, water pumps, and brake discs. By supplying a comprehensive selection of spare parts from a single source, Klaxcar aims to meet the needs of the automobile sector effectively.
NetCo
Venture Round in 2016
Groupe NetCo specializes in the design, manufacture, assembly, maintenance, and installation of conveyor systems, including both belt and roller types. The company offers a diverse range of conveyor belts made from rubber and various polymers, along with specialized accessories such as wipers, rollers, and drive pulleys. NetCo also provides services like on-site installation, training for conveyor belt operation, and custom transformations of conveyor belts. Serving a wide array of industries, including waste management, logistics, agrifood, pharmaceuticals, and energy sectors, the company has established itself as a leader in the domestic market within a decade of operation. Founded in 1902 and based in Bordeaux, France, Groupe NetCo was previously known as PERRIEZ and rebranded in 1999.
MS Vacances
Venture Round in 2016
MS Vacances SAS, established in 1992 and located in Nantes, France, specializes in the hospitality sector by providing boarding and lodging services. The company operates holiday homes across France and offers a range of mobile leisure accommodations, incorporating amenities such as camping facilities, indoor pools, bars, restaurants, grocery services, and laundry facilities. Additionally, MS Vacances is known for its premium air travel services in the Atlantic and Mediterranean regions, enhancing the overall holiday experience for its customers.
Ipside
Venture Round in 2016
Ipside is a firm that specializes in providing industrial property attorney services, focusing on the protection and management of intellectual property rights for clients in various sectors, including telecommunications, software, aerospace, pharmaceuticals, biotechnology, and optoelectronics. The company assists clients in obtaining, operating, and defending their patents internationally, while also exploring additional methods to protect technical inventions. Ipside offers comprehensive litigation and consultancy services covering patent law, trademark law, design law, copyright law, and software rights. Through its expertise, the firm develops tailored strategies that address the legal and technical aspects of commercialization, enabling clients to effectively navigate the complexities of their intellectual property and ensure robust protection for their innovative solutions.
Sogetrel
Private Equity Round in 2016
Sogetrel, S.A.S. is a prominent company specializing in the design, deployment, and maintenance of network infrastructures and digital communication solutions. Established in 1985 and headquartered in Issy les Moulineaux, France, Sogetrel operates branches in Belgium and Switzerland. The company provides a range of services, including the integration of telecommunications networks, IP security systems for video surveillance and access control, and support for smart city projects. Sogetrel serves a diverse clientele across various sectors such as telecommunications, public authorities, defense, transport, and utilities. By focusing on the development of very high-speed networks and offering both customized and turnkey solutions, Sogetrel aims to enhance the quality of life for citizens while promoting efficiency and sustainability in the regions it serves.
REALEASE Capital
Private Equity Round in 2015
REALEASE Capital is a French company based in Puteaux that provides leasing and financing solutions for manufacturers of materials used in videoconferencing and other technological assets. Founded in 1986, the company specializes in the progressive rental of a diverse range of equipment, including IT, telecom, industrial, audiovisual, medical, and digital devices. Through its financial services, REALEASE Capital aims to support businesses in acquiring essential technology without the burdens of outright purchase, thereby facilitating access to innovative tools across various sectors.
Groupe ERGET
Venture Round in 2015
Groupe ERGET SA is a French company specializing in surveying and loss adjustment, founded in 1986 and headquartered in Neuilly-sur-Seine, France. The company provides expertise in various sectors, including construction, aviation, energy, industry, safety, fire protection, and product liability, serving a diverse clientele that includes insurers, brokers, industrialists, and legal professionals. With a workforce of 120 employees, including 85 multidisciplinary surveyors, Groupe ERGET has expanded its international presence since 2006, operating in regions such as Asia, South America, and the West Indies, along with establishing a joint venture across over 30 African countries. The company has completed more than 5,500 missions in 115 countries, generating a turnover of 20 million euros, with 35% of its revenue derived from international operations. Through its strategic acquisitions and growth initiatives, Groupe ERGET aims to solidify its position as a leader in the francophone market and continue expanding into emerging markets.
ACE Group
Venture Round in 2015
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company provides a range of services aimed at facilitating mortgage solutions for individuals and businesses seeking to finance property purchases. With a focus on understanding client needs and market conditions, ACE Group aims to deliver tailored financial solutions that support clients in navigating the complexities of real estate financing. By leveraging industry expertise and market insights, ACE Group positions itself as a key player in the mortgage brokerage sector in France.
ACE Group
Private Equity Round in 2015
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company provides a range of services aimed at facilitating mortgage solutions for individuals and businesses seeking to finance property purchases. With a focus on understanding client needs and market conditions, ACE Group aims to deliver tailored financial solutions that support clients in navigating the complexities of real estate financing. By leveraging industry expertise and market insights, ACE Group positions itself as a key player in the mortgage brokerage sector in France.
Emeraude International
Private Equity Round in 2014
Emeraude International SA is a distributor of polymers and chemicals, specializing in a diverse range of products, including polyolefins and thermoplastics. The company offers blown film extrusion polymers used in agricultural films, food packaging, and flexible packaging, as well as blow molding polymers for beverage and cosmetic containers. Additionally, Emeraude provides pipe extrusion polymers for various applications, including telecommunications, and injection molding polymers for creating household items, garden furniture, and industrial components. With a strong focus on supply chain solutions and tailored logistics, Emeraude International serves a global clientele, primarily in Africa, the Indian subcontinent, Europe, and Southeast Asia. Established in 1986 and headquartered in Paris, France, the company has expanded its presence with additional offices in France and internationally.
Finsecur
Venture Round in 2014
Finsecur S.A., established in 2000, is a French high-tech company specializing in the design, manufacturing, and maintenance of fire safety systems. Based in Paris, France, the company produces a range of products including fire detectors, control panels, accessories, alarm systems, extinguishant systems, and technical alarms for various industries such as clean rooms, agro-alimentary facilities, telecoms, airports, chemistry, military sectors, and warehouses. Finsecur was recognized with the BPI label Excellence, reflecting its innovative approach to fire safety solutions.
A2iA
Private Equity Round in 2014
A2iA S.A. is a developer of advanced software solutions focused on handwritten and machine-printed text recognition, information extraction, and intelligent document classification. The company offers various toolkits, including a2ia Mobility, which supports multiple workflows for document processing; a2ia mNote, which digitizes handwritten notes directly on mobile devices; and a2ia DocumentReader, designed for data extraction from diverse document types. Additional products include a2ia TextReader for transcribing printed and cursive text, a2ia CheckReader for secure data capture from payment documents, and a2ia FieldReader for extracting information from forms. A2iA serves a wide range of industries, including banking, fintech, telecommunications, healthcare, insurance, and government, with a global presence across Europe, North America, Latin America, the Middle East, Africa, India, and the Asia Pacific. Founded in 1991 and headquartered in Paris, France, with an office in New York, A2iA operates as a subsidiary of Mitek Systems, Inc.
Maesa
Venture Round in 2014
Maesa is a company based in Levallois Perret, France, specializing in the design and manufacture of tailor-made perfumes, cosmetics, and promotional products. Founded in 1997, it operates across Europe, Asia, and North America. Maesa focuses on various aspects of product development, including brand identity, industrial design, package design, and graphic design. The company offers turnkey beauty products and home fragrance solutions for retailers and brands, and it also provides packaging components and promotional products for the beauty industry. In addition to its manufacturing capabilities, Maesa serves as a beauty brand incubator, creating exclusive brands and private labels for a range of retail sectors, including mass, drug, and specialty markets.
Thomson Video Networks
Private Equity Round in 2014
Thomson Video Networks SAS specializes in providing comprehensive video delivery solutions for broadcasters globally. The company offers a range of services, including satellite direct-to-home, digital terrestrial television, IPTV, web TV, and mobile TV solutions. Its product lineup features video compression systems such as HD and SD encoders, multiscreen video systems, and contribution codec platforms, alongside processing and multiplexing systems including MPEG multiplexers and video processors. Additionally, Thomson Video Networks provides advanced decoding systems, data casting solutions, and monitoring and switching systems to ensure efficient video signal management. The company also supports its clients with integration, consultancy, technical support, and training services. Established in 2010 and headquartered in Cesson-Sevigne, France, Thomson Video Networks operates as a subsidiary of Harmonic Inc.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
Groupe ADF
Private Equity Round in 2014
Groupe ADF SAS is an industrial maintenance and engineering services provider based in Vitrolles, France, founded in 1962. The company specializes in delivering maintenance solutions across various sectors, including aeronautics, space and defense, energy, and oil and gas. Its offerings encompass a wide range of services such as maintenance for the petrochemical and metallurgical industries, naval and port repairs, and pharmaceutical and agro-food sectors. Additionally, Groupe ADF provides turn-key solutions, revamping work, management of statutory stoppage work, and environmental services like waste management and industrial cleaning. The company is also involved in equipment integration and digital transformation to enhance production support and automate business processes.
Genticel is a French clinical-stage biotechnology company established in 2001 by Benedikt Timmerman. The company specializes in developing innovative immunotherapies aimed at treating viral infections and diseases associated with viruses, particularly focusing on human papillomavirus (HPV) and HPV-related conditions, such as cervical cancer. Genticel's product offerings include its proprietary technological platform, Vaxiclase, along with specific immunotherapy candidates GTL001 and GTL002. By concentrating on HPV and its implications, Genticel aspires to emerge as a leader in the field of immunotherapy across various medical indications.
ITESA
Private Equity Round in 2013
ITESA, established in Marseille, France since 1978, is an independent distributor specializing in security systems for professional clients. The company offers a comprehensive range of products including alarm panels, detection systems, barriers, signaling devices, transmission equipment, power supplies, cables, batteries, accessories, management products, biometric identification tools, video surveillance products, intercom systems, automation solutions, audio-visual equipment, and fire safety gear. ITESA sells these products primarily through agencies in France and Switzerland, focusing on providing innovative, high-quality items along with expert advice and services to help its partners excel in their field.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
OCEAN SAS
Venture Round in 2011
OCEAN SAS, founded in 2003 and headquartered in Clichy, France, specializes in providing vehicle tracking solutions. The company offers fleet management services, monitoring and controlling the on-the-road activities of its clients. OCEAN's vehicle tracking system provides real-time information about vehicles and their drivers. Additionally, it customizes management solutions to meet specific client needs, including integration with personal digital assistants, in-car printers, WAP access, vehicle neutralization, driver identification keys, data transfer, and tailored applications.
Novamex SA
Private Equity Round in 2011
Novamex S.A. produces natural and eco-friendly cleaning, washing, and personal hygiene products to individuals and companies in France. It offers washing powders and liquids, cleaning liquids, shampoos, moisturizers, and hair conditioning products.
SuperSonic Imagine
Series C in 2010
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.
Garden Price
Venture Round in 2010
Garden Price is a Les Nouvelles Jardineries, a Maurepas, France-based chain of low-cost garden stores.
Implanet S.A. is a medical device company based in Martillac, France, specializing in the design, manufacture, and sale of orthopedic implants and devices. Founded in 2006, the company offers a range of products for orthopedic surgery, including spinal systems, knee prostheses, and arthroscopy tools. Notable offerings include the Jazz series of posterior fixation systems and the Madison knee prosthesis, designed for conventional surgical techniques. Implanet aims to provide high-quality, innovative solutions that enhance the productivity of healthcare professionals while addressing the need for cost-effective healthcare. The company primarily serves markets in France, the United States, Brazil, and internationally, ensuring that its products meet the evolving needs of orthopedic care providers.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
Implanet S.A. is a medical device company based in Martillac, France, specializing in the design, manufacture, and sale of orthopedic implants and devices. Founded in 2006, the company offers a range of products for orthopedic surgery, including spinal systems, knee prostheses, and arthroscopy tools. Notable offerings include the Jazz series of posterior fixation systems and the Madison knee prosthesis, designed for conventional surgical techniques. Implanet aims to provide high-quality, innovative solutions that enhance the productivity of healthcare professionals while addressing the need for cost-effective healthcare. The company primarily serves markets in France, the United States, Brazil, and internationally, ensuring that its products meet the evolving needs of orthopedic care providers.
Genticel is a French clinical-stage biotechnology company established in 2001 by Benedikt Timmerman. The company specializes in developing innovative immunotherapies aimed at treating viral infections and diseases associated with viruses, particularly focusing on human papillomavirus (HPV) and HPV-related conditions, such as cervical cancer. Genticel's product offerings include its proprietary technological platform, Vaxiclase, along with specific immunotherapy candidates GTL001 and GTL002. By concentrating on HPV and its implications, Genticel aspires to emerge as a leader in the field of immunotherapy across various medical indications.
Smile
Venture Round in 2010
Smile is a provider of software integration and maintenance services based in Levallois-Perret, France. The company specializes in open source solutions, aiming to unlock innovation potential for businesses by leveraging its technical and business expertise. Smile's offerings encompass a wide range of areas, including digital evolution, business applications, embedded technologies, the Internet of Things (IoT), and infrastructure management. By focusing on these domains, Smile helps organizations optimize their operations and enhance their digital capabilities.
Implanet S.A. is a medical device company based in Martillac, France, specializing in the design, manufacture, and sale of orthopedic implants and devices. Founded in 2006, the company offers a range of products for orthopedic surgery, including spinal systems, knee prostheses, and arthroscopy tools. Notable offerings include the Jazz series of posterior fixation systems and the Madison knee prosthesis, designed for conventional surgical techniques. Implanet aims to provide high-quality, innovative solutions that enhance the productivity of healthcare professionals while addressing the need for cost-effective healthcare. The company primarily serves markets in France, the United States, Brazil, and internationally, ensuring that its products meet the evolving needs of orthopedic care providers.
SuperSonic Imagine
Series B in 2008
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.
EOS Imaging
Venture Round in 2007
EOS Imaging SA is a medical technology company based in Paris, France, specializing in low-dose 2D/3D imaging and software solutions for osteo-articular conditions and orthopedic surgeries. The company develops and markets the EOS imaging system, which produces full-body, stereo-radiographic images of patients in functional positions, tailored to the specific needs of orthopedic surgeons and radiologists. Its product offerings include EOSedge, a high-quality X-ray system, sterEOS, a 3D modeling workstation for precise skeletal analysis, and EOSapps, online surgical planning solutions based on real-time imaging. Additionally, EOS Imaging creates planning software for knee and hip surgeries and manufactures patient-specific cutting guides for orthopedic procedures. The company operates globally, with a presence in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America, and has obtained marketing authorization for its systems in 48 countries. Founded in 1989, EOS Imaging was previously known as biospace med before rebranding in 2010.
Implanet S.A. is a medical device company based in Martillac, France, specializing in the design, manufacture, and sale of orthopedic implants and devices. Founded in 2006, the company offers a range of products for orthopedic surgery, including spinal systems, knee prostheses, and arthroscopy tools. Notable offerings include the Jazz series of posterior fixation systems and the Madison knee prosthesis, designed for conventional surgical techniques. Implanet aims to provide high-quality, innovative solutions that enhance the productivity of healthcare professionals while addressing the need for cost-effective healthcare. The company primarily serves markets in France, the United States, Brazil, and internationally, ensuring that its products meet the evolving needs of orthopedic care providers.
Domain Therapeutics
Series C in 2006
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.
Cytomics Pharmaceuticals
Series B in 2006
Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.
Cellectis
Series C in 2005
Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.
Nautilus Biotech
Venture Round in 2005
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
Domain Therapeutics
Series B in 2004
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.
Cellectis
Series B in 2002
Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.